Assistant Professor, Pathology, University of Colorado School of Medicine
Pathology
Dr. Dara L. Aisner, MD
|
|
Give Review
Dara L. Aisner, MD works in the field of Pathology. He went to University of Texas Southwestern Medical School. Dara Aisner is a published MD as well. He has 30 publications published. The latest was: HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers. He accepts Medicare.
Publications
- HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers.
- A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metast...
- BRAF VE1 Immunoreactivity Patterns in Epithelioid Glioblastomas Positive for BRAF V600E Mutation.
- Multi-institutional oncogenic driver mutation analysis in lung adenocarcinoma: The Lung Cancer Mutation Consortium experience.
- Giant Pulmonary Chondroid Hamartoma: Imaging and Pathology Correlation of a Rare Tumor Demonstrated With Bone Scintigraphy and 18F-FDG PET/CT.
- Massive Dissemination From Spinal Cord Gangliogliomas Negative for BRAF V600E: Report of Two Rare Adult Cases.
- EGFR Exon 19 Deletion Mutations and Systemic/Central Nervous System Miliary Metastasis: Clinical Correlations and Response to Therapy.
- Atypical Negative ALK Break-Apart FISH Harboring a Crizotinib-Responsive ALK Rearrangement in Non-Small-Cell Lung Cancer.
- Phase 1 study of oral rigosertib (ON 01910.Na), a dual inhibitor of the PI3K and Plk1 pathways, in adult patients with advanced solid malignancies.
- Is there clinical value to prognostic signatures in early stage NSCLC?
- ROS1 and ALK Fusions in Colorectal Cancer, with Evidence of Intra-tumoral Heterogeneity for Molecular Drivers.
- Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.
- Pediatric Brainstem Gangliogliomas Show BRAF(V600E) Mutation in a High Percentage of Cases.
- Native and rearranged ALK copy number and rearranged cell count in non-small cell lung cancer: Implications for ALK inhibitor therapy.
- Erlotinib Response in an NSCLC Patient with a Novel Compound G719D+L861R Mutation in EGFR.
- The dual pathway inhibitor rigosertib is effective in direct-patient tumor xenografts of head and neck squamous cell carcinomas.
- Epithelioid GBMs Show a High Percentage of BRAF V600E Mutation.
- Evaluation of EGFR mutation status in cytology specimens: an institutional experience.
- Anaplastic PXA in adults: case series with clinicopathologic and molecular features.
- Diagnostic assays for identification of anaplastic lymphoma kinase-positive non-small cell lung cancer.
- Resistance to ROS1 Inhibition Mediated by EGFR Pathway Activation in Non-Small Cell Lung Cancer.
- Cardiac involvement with human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: The NIH experience.
- A 20 gene model for predicting nodal involvement in bladder cancer patients with muscle invasive tumors.
- Atypical teratoid/rhabdoid tumor arising in a ganglioglioma: genetic characterization.
- Genetic testing for metastasis: potential for improved cancer treatment.
- Loss of S100 antigenicity in metastatic melanoma.
- Telomerase regulation: not just flipping the switch.
- An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity.
- Telomere dynamics in cells with introduced telomerase: a rapid assay for telomerase activity on telomeres.
Schools
University Of Texas Southwestern Medical Center At Dallas Southwestern Medical School
National Capital Consortium Bethesda Program
Doctors Specialties
- Molecular Genetic Pathology
- Pathology
Accepted Insurances
- Aetna HMO
- Great West Healthcare-Cigna PPO
- First Health (Coventry Health Care) PPO
- Humana
- Medicare MCR
- Principal Life
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
University of Pennsylvania Health System -
National Institutes of Health Clinical Center -
University of Texas Southwestern Medical School
Hospital
-
University of Colorado Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1538321831 |
| Last Name Of The Provider | AISNER |
| First Name Of The Provider | DARA |
| View All |
Similar Doctors
|
|
Dr. Katherine S. Messner, DO |
|
|
Dr. Gregary T. Bocsi, DO
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Daniel T. Merrick, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mark A. Lovell, MD |
|
|
Dr. Shalini Tayal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Valerica Mateescu, MD
This Doctor is OpenDoctor Recommended.
|